Behavior

Neurology·MeSH: Behavior

7 drugs in development·7 companies·6 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
fluphenazine	DR REDDYS LABORATORIES LTD (RDY)
perphenazine	Mylan II B.V. (MYL)
prochlorperazine edisylate	NEXUS BIOPHARMA INC (NEXS)
thiothixene	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 2(2)

Drug	Company
ITI-1284-ODT-SL	Intra-Cellular Therapies, Inc. (ITCI)
sls-002	SEELOS THERAPEUTICS, INC. (SEEL)

Preclinical(1)

Drug	Company
rad011	Radius Health, Inc. (RDUS)

BioSniper tracks 7 drugs in development for Behavior across 7 companies.

There are 6 clinical trials targeting Behavior tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.